Guidelines for breast cancer management in Bosnia and Herzegovina.
| العنوان: | Guidelines for breast cancer management in Bosnia and Herzegovina. |
|---|---|
| المؤلفون: | Hadžikadić-Gušić L; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Cerić T; Department of Medical Oncology, University Clinical Center, Sarajevo, BiH., Marijanović I; Department of Medical Oncology, University Clinical Center, Mostar, BiH., Iljazović E; Department of Pathology, University Clinical Center, Tuzla, BiH., Koprić D; Department of Pathology, University Clinical Center, Tuzla, BiH., Zorlak A; Genetics Counseling, Genetika, Sarajevo, BiH., Tanović M; Department of Plastic and Reconstructive Surgery, Advanced Plastic Surgery of North Shore, NY, USA., Mekić-Abazović A; Department of Medical Oncology, Kanton Hospital Zenica, Zenica, BiH., Šišić I; Department of Medical Oncology, Kanton Hospital Zenica, Zenica, BiH., Delić U; Department of Medical Oncology, University Clinical Center, Sarajevo, BiH., Mustedanagić-Mujanović J; Department of Pathology, University Clinical Center, Tuzla, BiH., Aginčić A; Department of Plastic and Reconstructive Surgery, Our Little Clinic, Sarajevo, BiH., Bećiragić E; Department of Surgery, Dr. Abdulah Nakas General Hospital, Sarajevo, BiH., Greene F; Department of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. |
| المصدر: | Biomolecules and biomedicine [Biomol Biomed] 2023 Feb 01; Vol. 23 (1), pp. 2-14. Date of Electronic Publication: 2023 Feb 01. |
| نوع المنشور: | Guideline |
| اللغة: | English |
| بيانات الدورية: | Publisher: Association of Basic Medical Sciences of FBIH Country of Publication: Bosnia and Herzegovina NLM ID: 9918522188506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2831-090X (Electronic) Linking ISSN: 28310896 NLM ISO Abbreviation: Biomol Biomed Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Sarajevo : Association of Basic Medical Sciences of FBIH, [2023]- |
| مواضيع طبية MeSH: | Breast Neoplasms*/diagnosis , Medicine*, Humans ; Female ; United States ; Bosnia and Herzegovina/epidemiology ; Interdisciplinary Studies ; Academies and Institutes |
| مستخلص: | Breast cancer is the most common cancer among women. In Bosnia and Herzegovina, accurate data on the status of breast cancer are lacking due to the absence of a central registry. Multiple international guidelines imply that institutions that monitor breast cancer patients should have optimal therapeutic options for treatment. In addition, there have been several international consensus guidelines written on the management of breast cancer. Application of consensus guidelines has previously been demonstrated to have a positive influence on breast cancer care. The importance of specialty breast centers has previously been reported. As part of the 2021 Bosnian-Herzegovinian American Academy of Arts and Sciences (BHAAAS) conference in Mostar, a round table of multidisciplinary specialists from Bosnia and Herzegovina and the diaspora was held. All were either members of BHAAAS or regularly participate in collaborative projects. The focus of the consortium was to write the first multidisciplinary guidelines for the general management of breast cancer in Bosnia and Herzegovina. Guidelines were developed for each area of breast cancer treatment and management. These guidelines will serve as a resource for practitioners managing breast cancer in the Bosnia and Herzegovina region. This might also be of benefit to the ministry of health and any future investors interested in developing breast cancer care policies in this region of the world. |
| References: | AJR Am J Roentgenol. 2003 Apr;180(4):901-10. (PMID: 12646427) J Clin Med. 2018 May 31;7(6):. (PMID: 29857526) JAMA. 2021 Jan 5;325(1):36-38. (PMID: 33300953) Ann Surg Oncol. 2011 Oct;18(11):3117-22. (PMID: 21847697) J Surg Oncol. 2013 Jun;107(8):815-21. (PMID: 23505028) N Engl J Med. 2004 Dec 30;351(27):2817-26. (PMID: 15591335) Eur J Cancer. 2012 Dec;48(18):3355-77. (PMID: 23116682) Bosn J Basic Med Sci. 2019 Aug 20;19(3):227-233. (PMID: 30915922) Clin Oncol (R Coll Radiol). 2017 Oct;29(10):653-661. (PMID: 28728883) Breast Cancer Res Treat. 2017 Sep;165(2):273-283. (PMID: 28589366) Ann Surg Oncol. 2009 Nov;16(11):3000-9. (PMID: 19603233) Br J Surg. 2019 Oct;106(11):1488-1494. (PMID: 31386197) Ann Surg Oncol. 2015 May;22(5):1416-24. (PMID: 25727555) Plast Reconstr Surg. 2004 Mar;113(3):877-81. (PMID: 15108879) Ann Surg Oncol. 2004 Mar;11(3 Suppl):208S-10S. (PMID: 15023753) Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820960721. (PMID: 32990165) Breast Cancer Res Treat. 2013 Nov;142(2):445-53. (PMID: 24141896) Ann Surg Oncol. 2012 Aug;19(8):2572-9. (PMID: 22446897) Lancet. 2020 May 23;395(10237):1613-1626. (PMID: 32580883) Bosn J Basic Med Sci. 2021 Apr 01;21(2):120-135. (PMID: 32415816) Lancet Oncol. 2021 Apr;22(4):476-488. (PMID: 33721561) Int J Cancer. 2021 Feb 15;148(4):941-949. (PMID: 32720318) Eur Radiol. 2004 Oct;14(10):1725-31. (PMID: 15248080) Stat Med. 2004 Apr 15;23(7):1111-30. (PMID: 15057881) J Magn Reson Imaging. 2006 Nov;24(5):964-70. (PMID: 17036340) Breast. 2014 Jun;23(3):209-20. (PMID: 24767882) JAMA Oncol. 2020 Sep 1;6(9):1390-1396. (PMID: 32789480) Radiology. 2018 Jun;287(3):771-777. (PMID: 29388904) Oncology (Williston Park). 1997 Jun;11(6 Suppl 6):37-40. (PMID: 9213327) Breast Cancer (Auckl). 2020 Dec 16;14:1178223420980377. (PMID: 33402827) J Clin Oncol. 2008 Jan 20;26(3):386-91. (PMID: 18202414) J Surg Oncol. 2017 Mar;115(3):231-237. (PMID: 28105662) J Cancer Surviv. 2013 Mar;7(1):83-92. (PMID: 23212603) Breast. 2019 Aug;46:116-125. (PMID: 31146185) Indian J Surg. 2016 Oct;78(5):396-401. (PMID: 27994336) J Clin Oncol. 2016 Dec 20;34(36):4431-4442. (PMID: 27646947) Magn Reson Imaging Clin N Am. 2006 Aug;14(3):351-62, vi. (PMID: 17098176) Eur J Cancer. 2022 Jul;170:54-63. (PMID: 35594612) Breast Cancer Res Treat. 2017 Jun;163(3):615-622. (PMID: 28315967) Eur J Radiol. 2017 Sep;94:148-153. (PMID: 28712698) N Engl J Med. 2002 Oct 17;347(16):1233-41. (PMID: 12393820) Lancet Oncol. 2014 Nov;15(12):1303-10. (PMID: 25439688) Plast Reconstr Surg. 2007 Jun;119(7):2092-2100. (PMID: 17519706) Ann Surg Oncol. 2012 Feb;19(2):536-40. (PMID: 21751044) N Engl J Med. 2018 Jul 12;379(2):111-121. (PMID: 29860917) Eur J Cancer. 2011 Apr;47(6):879-86. (PMID: 21195605) J Intern Med. 2013 Aug;274(2):113-26. (PMID: 23844915) Eur Radiol. 2019 May;29(5):2526-2534. (PMID: 30617471) Breast Cancer (Dove Med Press). 2017 Apr 18;9:257-263. (PMID: 28458578) Ann Surg Oncol. 2018 Oct;25(11):3141-3149. (PMID: 29777404) Cancer. 2017 Apr 15;123(8):1324-1332. (PMID: 27984658) J Clin Oncol. 2019 Feb 20;37(6):453-460. (PMID: 30526229) Ann Surg Oncol. 2020 Mar;27(3):724-729. (PMID: 31863417) BMC Cancer. 2020 Aug 10;20(1):746. (PMID: 32778072) Plast Reconstr Surg. 2010 Jun;125(6):1606-1614. (PMID: 20517083) J Oncol Pract. 2018 Jul;14(7):437-441. (PMID: 29920138) Radiat Oncol J. 2016 Jun;34(2):81-7. (PMID: 27306774) Clin Breast Cancer. 2008 Jun;8(3):224-33. (PMID: 18650152) Am Surg. 2004 May;70(5):420-4. (PMID: 15156950) Ann Surg. 2010 Sep;252(3):426-32; discussion 432-3. (PMID: 20739842) Ann Surg Oncol. 2014 May;21(5):1552-60. (PMID: 24385207) J Clin Oncol. 2004 Sep 15;22(18):3685-93. (PMID: 15289491) Lancet. 2010 Feb 13;375(9714):563-71. (PMID: 20159292) Genet Res (Camb). 2021 Jan 9;2021:6611963. (PMID: 33762893) Ann Surg Oncol. 2013 Nov;20(12):3823-30. (PMID: 23780381) Ann Surg Oncol. 2016 Aug;23(8):2380-2. (PMID: 27075322) AJR Am J Roentgenol. 2003 Feb;180(2):333-41. (PMID: 12540428) Br J Surg. 2015 Dec;102(13):1649-57. (PMID: 26445887) Radiology. 2013 Apr;267(1):57-66. (PMID: 23329656) N Engl J Med. 2019 Feb 14;380(7):617-628. (PMID: 30516102) J Clin Oncol. 2022 Mar 20;40(9):978-987. (PMID: 34995128) Br J Surg. 2015 Jul;102(8):883-93. (PMID: 25919321) Breast. 2017 Oct;35:203-217. (PMID: 28822332) Genet Med. 2020 Feb;22(2):407-415. (PMID: 31406321) Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):69-76. (PMID: 20732766) J Am Coll Surg. 2020 Mar;230(3):331-339. (PMID: 31945462) Br J Radiol. 2016;89(1060):20150679. (PMID: 26853509) Am J Surg. 2016 Jun;211(6):1089-94. (PMID: 26552997) Br J Cancer. 2021 Jan;124(1):13-26. (PMID: 33239679) Breast Cancer Res Treat. 2013 Apr;138(2):549-59. (PMID: 23430224) AJR Am J Roentgenol. 2014 Jun;202(6):1376-82. (PMID: 24848838) Cancer. 2012 Jul 1;118(13):3226-8. (PMID: 22086839) Clin Breast Cancer. 2014 Apr;14(2):114-21. (PMID: 24321101) World J Surg. 2014 Jul;38(7):1685-93. (PMID: 24817517) Radiology. 2015 Sep;276(3):695-705. (PMID: 25915100) Cureus. 2021 Oct 2;13(10):e18433. (PMID: 34729260) N Engl J Med. 2011 Feb 3;364(5):412-21. (PMID: 21247310) Lancet Oncol. 2015 Oct;16(13):1380-8. (PMID: 26363985) Bosn J Basic Med Sci. 2021 Feb 01;21(1):1-4. (PMID: 32530388) Breast. 2020 Jun;51:65-84. (PMID: 32217457) Bosn J Basic Med Sci. 2006 Nov;6(4):67-71. (PMID: 17177654) Bosn J Basic Med Sci. 2019 Aug 20;19(3):242-248. (PMID: 30957723) Plast Reconstr Surg. 2013 Jan;131(1):15-23. (PMID: 23271515) Breast J. 2017 Mar;23(2):200-205. (PMID: 28191695) Am J Hum Genet. 2001 Mar;68(3):700-10. (PMID: 11179017) N Engl J Med. 2004 Sep 2;351(10):971-7. (PMID: 15342805) Ann Surg. 2013 Feb;257(2):249-55. (PMID: 23187751) Ann Surg Oncol. 2019 Oct;26(10):3025-3031. (PMID: 31342359) JAMA. 2015 Oct 20;314(15):1599-614. (PMID: 26501536) Curr Oncol Rep. 2020 Apr 29;22(5):51. (PMID: 32346807) JAMA. 2013 Oct 9;310(14):1455-61. (PMID: 24101169) Med Care. 2008 Aug;46(8):762-70. (PMID: 18665055) J Natl Cancer Inst. 2010 Apr 7;102(7):456-63. (PMID: 20220104) J Clin Oncol. 2014 Feb 10;32(5):392-401. (PMID: 24395846) Lancet Oncol. 2020 Sep;21(9):1165-1172. (PMID: 32800099) N Engl J Med. 2018 Jul 12;379(2):122-137. (PMID: 29863451) Crit Rev Oncol Hematol. 2009 Aug;71(2):102-16. (PMID: 18922700) Surg Oncol Clin N Am. 2014 Jul;23(3):431-49. (PMID: 24882343) J Oncol. 2020 Mar 16;2020:5169278. (PMID: 32256583) Plast Reconstr Surg. 2009 Aug;124(2):345-353. (PMID: 19644246) Transl Cancer Res. 2019 Mar;8(Suppl 2):S84-S86. (PMID: 35117069) Chest. 2006 Jan;129(1):174-81. (PMID: 16424429) |
| تواريخ الأحداث: | Date Created: 20220726 Date Completed: 20230202 Latest Revision: 20230210 |
| رمز التحديث: | 20230210 |
| مُعرف محوري في PubMed: | PMC9901905 |
| DOI: | 10.17305/bjbms.2022.7504 |
| PMID: | 35880400 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2831-090X |
|---|---|
| DOI: | 10.17305/bjbms.2022.7504 |